Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 28 | 2021 | 568 | 3.280 |
Why?
|
| Arthroplasty, Replacement, Hip | 22 | 2016 | 746 | 1.600 |
Why?
|
| Knee Joint | 10 | 2016 | 673 | 1.220 |
Why?
|
| Knee Prosthesis | 13 | 2021 | 204 | 1.190 |
Why?
|
| Reoperation | 26 | 2021 | 818 | 0.900 |
Why?
|
| Tendons | 3 | 2006 | 209 | 0.640 |
Why?
|
| Minimally Invasive Surgical Procedures | 6 | 2007 | 280 | 0.600 |
Why?
|
| Patella | 5 | 2006 | 62 | 0.580 |
Why?
|
| Prosthesis Design | 16 | 2021 | 447 | 0.580 |
Why?
|
| Femur | 8 | 2010 | 359 | 0.570 |
Why?
|
| Osteoarthritis, Knee | 4 | 2017 | 328 | 0.560 |
Why?
|
| Postoperative Complications | 12 | 2021 | 827 | 0.510 |
Why?
|
| Humans | 53 | 2021 | 25692 | 0.480 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2006 | 73 | 0.480 |
Why?
|
| Prosthesis Failure | 15 | 2021 | 475 | 0.470 |
Why?
|
| Tibia | 5 | 2019 | 230 | 0.450 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 28 | 0.440 |
Why?
|
| Range of Motion, Articular | 9 | 2016 | 625 | 0.420 |
Why?
|
| Treatment Outcome | 18 | 2016 | 3231 | 0.400 |
Why?
|
| Sound Spectrography | 1 | 2010 | 18 | 0.360 |
Why?
|
| Hip Fractures | 1 | 2010 | 18 | 0.350 |
Why?
|
| Blood Loss, Surgical | 2 | 2007 | 52 | 0.330 |
Why?
|
| Middle Aged | 24 | 2021 | 8403 | 0.320 |
Why?
|
| Aged | 23 | 2021 | 8501 | 0.320 |
Why?
|
| Orthopedic Procedures | 3 | 2016 | 272 | 0.320 |
Why?
|
| Perioperative Care | 2 | 2006 | 43 | 0.310 |
Why?
|
| Joint Diseases | 2 | 2016 | 101 | 0.310 |
Why?
|
| Hip Prosthesis | 7 | 2016 | 499 | 0.290 |
Why?
|
| Hemostasis, Surgical | 1 | 2007 | 13 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2007 | 217 | 0.280 |
Why?
|
| Electrocoagulation | 1 | 2007 | 12 | 0.280 |
Why?
|
| Male | 26 | 2021 | 13917 | 0.280 |
Why?
|
| Female | 26 | 2021 | 14273 | 0.280 |
Why?
|
| Recovery of Function | 7 | 2016 | 255 | 0.270 |
Why?
|
| Polyethylenes | 1 | 2006 | 31 | 0.270 |
Why?
|
| Critical Pathways | 1 | 2006 | 20 | 0.260 |
Why?
|
| Femoral Fractures | 1 | 2006 | 33 | 0.260 |
Why?
|
| Follow-Up Studies | 14 | 2021 | 1689 | 0.260 |
Why?
|
| Tendon Injuries | 2 | 2005 | 199 | 0.260 |
Why?
|
| Radiography | 10 | 2016 | 574 | 0.250 |
Why?
|
| Acetabulum | 7 | 2009 | 208 | 0.240 |
Why?
|
| Cementation | 5 | 2021 | 29 | 0.230 |
Why?
|
| Lactones | 1 | 2003 | 9 | 0.220 |
Why?
|
| Pain, Postoperative | 2 | 2006 | 293 | 0.220 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 27 | 0.220 |
Why?
|
| Isoenzymes | 1 | 2003 | 51 | 0.220 |
Why?
|
| Arthroplasty | 1 | 2004 | 130 | 0.220 |
Why?
|
| Hip Joint | 5 | 2016 | 492 | 0.220 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 30 | 0.190 |
Why?
|
| Osteoarthritis, Hip | 2 | 2016 | 94 | 0.170 |
Why?
|
| Adult | 15 | 2019 | 7336 | 0.170 |
Why?
|
| Time Factors | 7 | 2011 | 1336 | 0.160 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 607 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2009 | 1633 | 0.150 |
Why?
|
| Retrospective Studies | 9 | 2019 | 3220 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 45 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2016 | 31 | 0.130 |
Why?
|
| Joint Instability | 3 | 2016 | 365 | 0.130 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2016 | 7 | 0.130 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 9 | 0.130 |
Why?
|
| Braces | 1 | 2016 | 20 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 62 | 0.120 |
Why?
|
| Hip Dislocation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 46 | 0.120 |
Why?
|
| Aged, 80 and over | 9 | 2010 | 4459 | 0.120 |
Why?
|
| Transplantation, Homologous | 2 | 2005 | 248 | 0.110 |
Why?
|
| Knee Injuries | 1 | 2016 | 179 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 350 | 0.110 |
Why?
|
| Bone Cements | 4 | 2009 | 84 | 0.110 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2011 | 23 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 157 | 0.100 |
Why?
|
| Patient Selection | 1 | 2014 | 170 | 0.100 |
Why?
|
| Orthopedics | 2 | 2005 | 101 | 0.100 |
Why?
|
| Osteotomy | 2 | 2003 | 155 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2016 | 1781 | 0.090 |
Why?
|
| Vibration | 1 | 2010 | 27 | 0.090 |
Why?
|
| Pain Measurement | 3 | 2016 | 415 | 0.090 |
Why?
|
| Device Removal | 2 | 2009 | 85 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2016 | 396 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 238 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 2 | 0.070 |
Why?
|
| Arthroscopy | 1 | 2016 | 950 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2007 | 32 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 139 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2019 | 292 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 20 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 134 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 28 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2006 | 53 | 0.060 |
Why?
|
| Supine Position | 1 | 2006 | 21 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 207 | 0.060 |
Why?
|
| Medical Laboratory Science | 1 | 2005 | 7 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 136 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 29 | 0.060 |
Why?
|
| Rupture | 1 | 2004 | 105 | 0.060 |
Why?
|
| Bone Transplantation | 1 | 2006 | 184 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2016 | 618 | 0.060 |
Why?
|
| Dyssomnias | 1 | 2003 | 6 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 23 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 26 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 19 | 0.060 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 14 | 0.060 |
Why?
|
| Sulfones | 1 | 2003 | 18 | 0.060 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2003 | 20 | 0.060 |
Why?
|
| Analgesia, Epidural | 1 | 2003 | 48 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 67 | 0.050 |
Why?
|
| Inhalation | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2003 | 9 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2003 | 151 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 45 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2016 | 116 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 300 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 110 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 209 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 284 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 664 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 190 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 244 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 117 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 108 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 35 | 0.040 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 20 | 0.030 |
Why?
|
| Osteolysis | 2 | 2010 | 125 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 110 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 10 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 21 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 43 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 123 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 450 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 913 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 383 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2004 | 75 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2016 | 308 | 0.030 |
Why?
|
| Risk Factors | 2 | 2010 | 2224 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 5 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 63 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 223 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 58 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 255 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 62 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 54 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 105 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 90 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 168 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 2006 | 15 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 472 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2005 | 4 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 5 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 22 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2005 | 246 | 0.010 |
Why?
|
| Porosity | 1 | 2004 | 60 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 30 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 71 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 124 | 0.010 |
Why?
|
| Bone Wires | 1 | 2003 | 6 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 119 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 126 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 281 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 392 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1084 | 0.010 |
Why?
|
| United States | 1 | 2005 | 1943 | 0.010 |
Why?
|